Skip to main content
. 2014 May 6;9(5):e96384. doi: 10.1371/journal.pone.0096384

Table 3. Response to chemotherapy and serum YKL-40 levels.

Clinical response All patients YKL-40 (high) (%) YKL-40 (low) (%) p-value
CR 32 14 (43.8) 18 (56.2)
PR 33 24 (72.7) 9 (27.3)
SD 35 28 (80.0) 7 (20.0)
PD 20 15 (75.0) 5 (25.0)
Response (CR+PR) 65 38 (58.5) 27 (41.5) 0.031*
Non-response (SD+PD) 55 43 (78.2) 12 (21.8)

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.

*Significant difference.